Skip to main content

Table 2 Details of included studies

From: Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review

Author/Ref. Year/country Previous therapy Group No. Median age Gender (M:F) Interventions Median follow-up time (m)
Chao Zou 2015 Resection + TACE IFN 102 53 91:11 IFN
Control 126 52 113:13 IFN + TACE.
Li N 2010 Resection IFN 43 53.2 31:12 IFN
Control 36 51.2 26:10 ST
Sun, HC 2006 China Resection IFN 118 52.2 106:12 IFN 36.5
Control 118 50.4 102:16 ST
Lo, CM 2007 China Resection IFN 40 49 31:9 IFN Minimum follow-up 30
Control 40 54 34:6 ST
Li, MQ 2009 China TACE IFN 108 NA 77:31 IFN 24.8
Control 108 NA 74:34 ST
Chen, LT 2012 China Resection IFN 133 NA 108:25 IFN 63.8 (60.8–66.9)
Control 135 NA 112:23 ST
  1. TACE transarterial chemoembolization, ST symptomatic treatment